1. Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer. (22nd February 2019) Authors: Blumenthal, G M; Gong, Y; Kehl, K; Mishra-Kalyani, P; Goldberg, K B; Khozin, S; Kluetz, P G; Oxnard, G R; Pazdur, R Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗